chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Two middle fingers on my a I vaccination side are shake; Two middle fingers on my a I vaccination side are stif; I have allergies; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Two middle fingers on my a I vaccination side are shake), MUSCULOSKELETAL STIFFNESS (Two middle fingers on my a I vaccination side are stif) and HYPERSENSITIVITY (I have allergies) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergy.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TREMOR (Two middle fingers on my a I vaccination side are shake), MUSCULOSKELETAL STIFFNESS (Two middle fingers on my a I vaccination side are stif) and HYPERSENSITIVITY (I have allergies). At the time of the report, TREMOR (Two middle fingers on my a I vaccination side are shake), MUSCULOSKELETAL STIFFNESS (Two middle fingers on my a I vaccination side are stif) and HYPERSENSITIVITY (I have allergies) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
fevers 12JAN-14JAN; leg swollen, pt limping, poor appetite
Manufacture change the expiration date to 8/31/2022 after the vaccibe was administered.
The patient reports an episode lasting approxiately 5 minutes where she developed numbness and tingling in both hands and was unable to grasp objects. The patient presented to the clinic and was referred to the ED for further evaluation.
The employee reported she immediately felt something after receiving the vaccine.  Within 5 minutes her BP began to climb. She then developed chest pain, shortness of breath and tightening in the muscles of her left leg.  A Rapid Response was called and during this time she was noted to have a decrease in responsiveness.  911 was called and she was transported to a local hospital emergency department.  Her pulse oximetry and HR remained stable however, her BP was 200's/109.
A report received from a healthcare professional on 05Nov02 concerning a male vaccinee in his forties who experienced headache and redness, itching and burning immediately after receiving Fluvirin on 01Nov02.  On 01Nov02 the vaccinee complained of headache and of redness, itching and burning that extended from the upper arm to the elbow. No medical intervention was required as the symptoms were self-limiting. The symptoms resolved within 1 day and the pt has recovered from the event. There was insufficient information to determine the reporter's causality assessment. See Ref: PJP200200682, PJP200200684, PJP200200685, PJP200200686.
we wanted did a home test for COVID the PCR that you bring home /my test is positive.; we wanted did a home test for COVID the PCR that you bring home /my test is positive.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: drug ineffective, COVID-19, outcome unknown. The patient wanted to know they got the COVID booster from Pfizer on Tuesday. She wasn't feeling good up until today like the body ache, cold chills and headache the whole night. So, they wanted did a home test for COVID the PCR that you bring home and her husband same symptoms, his test was negative, her test was positive. The patient wanted to know could that be a false positive. The patient reported body ache, cold chills, bad cough, sore throat but did not have any symptoms up until got the booster. She just wants to know if they could be a false positive and those are really symptoms neither just all side effects from the shot. The lot number for bnt162b2 was not provided and will be requested during follow up.
sinus issues and fever; sinus issues and fever; This spontaneous case was reported by a consumer and describes the occurrence of SINUS DISORDER (sinus issues and fever) and PYREXIA (sinus issues and fever) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UL12L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SINUS DISORDER (sinus issues and fever) and PYREXIA (sinus issues and fever). At the time of the report, SINUS DISORDER (sinus issues and fever) and PYREXIA (sinus issues and fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive. On 04-Feb-2021, SARS-CoV-2 test: (Negative) Negative.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  No relevant concomitant medications were reported.  No treatment information was provided.
June 2 in the evening, developed fever of 103 deg F and developed hives all over the body Also had nausea/vomiting. The hives were pruritic. She took oral Benadryl with some relief. The fever was gone June 3. The hives lasted until June 6. She went to the doctor. Doctor did not know what they were from and prescribed antibiotics for a possible wound infection.
pressure on right side; paralysis on right side of body; numbness; sharp pain from neck up to face; sharp pain from neck up to face; racing of the heart with heart rate of 140; unable to swallow; This spontaneous case was reported by a consumer and describes the occurrence of HEMIPLEGIA (paralysis on right side of body) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, the patient experienced DYSPHAGIA (unable to swallow). On 18-May-2021, the patient experienced HEMIPLEGIA (paralysis on right side of body) (seriousness criterion medically significant), HYPOAESTHESIA (numbness), NECK PAIN (sharp pain from neck up to face), FACIAL PAIN (sharp pain from neck up to face) and PALPITATIONS (racing of the heart with heart rate of 140). On an unknown date, the patient experienced DISCOMFORT (pressure on right side). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 14-May-2021, DYSPHAGIA (unable to swallow) had resolved. At the time of the report, HEMIPLEGIA (paralysis on right side of body), HYPOAESTHESIA (numbness), NECK PAIN (sharp pain from neck up to face), FACIAL PAIN (sharp pain from neck up to face), PALPITATIONS (racing of the heart with heart rate of 140) and DISCOMFORT (pressure on right side) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-May-2021, Heart rate: 140 (High) 140.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment medications included Tylenol  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
mom took pt home & gave APAP & put pt down for a nap; slept 2 hrs when awoke pt was pale & lips bluish; it was approx 1230PM; mom took pt to family MD; t102;
MOC states body ache, fever, headache and rash on Pt face. Pt is abroad at present time and MOC did not state any treatment being done for child. We suggested alternate Ibuprofen and Tylenol to control the fever. Subject in question is over seas and has not been back in our office as of 12/18/19 all symptoms are from Mothers statement.
swelling of right arm that started just after injection, still present on 12/3/2009, also has some facial swelling
Starting 8/3/2011, started to get erythema around vaccine site left anterior thigh. By 8/5, injection site area broke out into shingles-appearing rash. No other symptoms except for mild fever, child is doing well.
Pt was given her COVID vaccine outside of it stability window (6  hrs after it was mixed). When this error was discovered, pt was contacted. Per pt she was doing ok and having mild symptoms (soreness and swelling at the injection site).  Patient is willing to come back sometime this weekend to get re-vaccinated per Pfizer & CDC guidance.
This spontaneous report as received from a registered nurse refers to 3 unspecified patients of unknown age. On 04-NOV-2014 (also reported as yesterday), the patients were vaccinated with ZOSTAVAX, (dose frequency, route of administration and indication were not provided), that were exposed to temperatures outside of the proper storage range. No concomitant were reported. No adverse effect reported. Outcome of events was unknown. No product quality complaint (PQC) was involved. No further information was provided. Additional information has been requested.
Puffy Tongue Facial Numbness and neck numbness  Metallic taste in mouth  Pins and needles/gradual  boiling sensation throughout whole body Aggressive vomiting  Hard time walking Nausea Dizziness Chills and high fever Inability to keep anything down Hypersensitivity to light, sound and touch Aches and pains all over
pt recv vax;mild asthma day p/ vax;rx @ home via nebulizer x3 & APAP x 3; no h/o fever;next am was found not breathing by grandma but had weak pulse;CPR given;called 911;to er;pt died 21may95;
High fever, intense body/joint aches, moderate headache, nausea, chills for hours, pain at injection site later turned to soreness, severe fatigue, incredible thirst (but it could be quenched)
Tender arm at injection site. Maybe some stiffness or muscle soreness in neck, but not sure it's related.
Headache, Myalgia, Arthralgia, SITE PAIN SWELLING REDNESS, SWEATS, FATIGUE Narrative:
This spontaneous report as received from a medical assistant refers to 2 or 3 patients of unknown age (gender not provided). On an unknown date the patients were vaccinated with two doses of GARDASIL (dose, route and lot # not reported) separately. The medical assistant reported that on an unknown date the "2 or 3 patients in the past" had received dose 2 of GARDASIL late. No symptoms reported. Additional information is not expected.
fever, profuse sweating, loss of consciousness, extreme heart racing, chest discomfort, nausea, nervousness, diarrhea, loss of appetite, fatigue
Per parents, the patient got his 2 month vaccines yesterday at 1330. The patient started to have a fever around 0100 and they gave him Tylenol. Highest fever at home was 100.6 F.
received a shingles vaccine one week before getting the Moderna vaccine; arm was red, swollen, and hot to the touch; Two weeks later, her side effects returned; red splotchy area on her arm; arm was red, swollen, and hot to the touch; pain in arm / pain in extremity; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received a shingles vaccine one week before getting the Moderna vaccine), VACCINATION SITE WARMTH (arm was red, swollen, and hot to the touch), SYMPTOM RECURRENCE (Two weeks later, her side effects returned), VACCINATION SITE PAIN (pain in arm / pain in extremity) and VACCINATION SITE ERYTHEMA (red splotchy area on her arm) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history.). Previously administered products included for an unreported indication: Vaccine for shingles (Vaccine for shingles) on 10-Feb-2021.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced VACCINATION SITE PAIN (pain in arm / pain in extremity). On 01-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received a shingles vaccine one week before getting the Moderna vaccine), VACCINATION SITE WARMTH (arm was red, swollen, and hot to the touch), SYMPTOM RECURRENCE (Two weeks later, her side effects returned), VACCINATION SITE ERYTHEMA (red splotchy area on her arm) and VACCINATION SITE SWELLING (arm was red, swollen, and hot to the touch). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received a shingles vaccine one week before getting the Moderna vaccine), VACCINATION SITE WARMTH (arm was red, swollen, and hot to the touch), SYMPTOM RECURRENCE (Two weeks later, her side effects returned), VACCINATION SITE PAIN (pain in arm / pain in extremity), VACCINATION SITE ERYTHEMA (red splotchy area on her arm) and VACCINATION SITE SWELLING (arm was red, swollen, and hot to the touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment information was not provided.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
At work patient had ALOC x10  minutes. Rapid response called. Transf to Hospital (12/18-12/20). D/C Dx ACUTE CORONARY SYNDROME (NON-STEMI)
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose 01/06/21pfizer,Lot#EL3246 2nd dose: 01/27/21,,Pfizer,Lot# EL9262 Diagnosed covid positive:07/24/21 symptoms began:07/23/21 Exposure:Travel Symptoms:loss of smell/taste, Headache.
Child has "shingles" on left arm of recrudescence VS2 infection from recent exposure-suggested culturing lesion by ID consult and reporting.
Within a few weeks of getting vaccinated patient had a lot of bruising on his legs and arms. Due to quantity of bruises I asked for a CBC to be done on him. His platelet count was 8 thousand. He was admitted to the hospital on 7/31/2020 and had a variety of tests performed. He was diagnosed with ITP and had IVIG treatment. His platelets increased to 64 thousand and he was released from the hospital on 8/2/2020.
jerking movements; keeps shaking her head and her arms/trembling; a couple of seizures; swelling on her arm; This is a spontaneous report from a contactable consumer (patient's parent). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration on 06Apr2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. Medical history included nonverbal, Cerebral Palsy and seizure disorder. The patient's concomitant medications were not reported. The patient had swelling on her arm when they got home from getting the vaccine and they gave her some Tylenol. On 07Apr2021, the patient has been having these jerking movements, something like if she had Parkinson's, it was a trembling. The patient kept shaking her head and her arms. After the shot, the patient had a couple of seizures when they got home on 06Apr2021, which is not uncommon because she has a seizure disorder and has them pretty frequently. The jerking that the patient was doing was not like her seizures. The patient did have Cerebral Palsy, a seizure disorder, and other conditions. The event outcome for events was unknown.
This is an instance of breakthrough COVID-19 after which death occurred.   They were vaccinated with the Moderna product on 04/21/2021 and 05/19/2021. They had a symptom onset of 11/16/2021 and tested positive for COVID-19 via antigen test at a clinic on 11/18/2021. They were also in the midst of a Shingles (Herpes Zoster) outbreak at the time of the positive COVID-19 test.  The individual had been vaccinated for Shingles (Shingrix) on 05/25/2021 (just a few days after their second COVID-19 vaccine) and 08/03/2021. They later presented to emergency department on  11/30/2021 via ambulance with CPR in progress. They died on 11/18/2021, soon after arrival to emergency department without being admitted to hospital.
tachycardia up to 140 resting HR; Blood pressure 180/98; super dizzy; super weak; tingling in hands and feet; hotness in left arm at the injection site; hotness in left shoulder; hotness in left neck; headache; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (tachycardia up to 140 resting HR), BLOOD PRESSURE INCREASED (Blood pressure 180/98), DIZZINESS (super dizzy), ASTHENIA (super weak) and PARAESTHESIA (tingling in hands and feet) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.   Concomitant products included LISDEXAMFETAMINE MESILATE (VYVANSE) for an unknown indication.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced TACHYCARDIA (tachycardia up to 140 resting HR), BLOOD PRESSURE INCREASED (Blood pressure 180/98), DIZZINESS (super dizzy), ASTHENIA (super weak), PARAESTHESIA (tingling in hands and feet), VACCINATION SITE WARMTH (hotness in left arm at the injection site), MUSCULOSKELETAL DISCOMFORT (hotness in left shoulder), MUSCULOSKELETAL DISCOMFORT (hotness in left neck) and HEADACHE (headache). On 23-Jan-2021, TACHYCARDIA (tachycardia up to 140 resting HR) and BLOOD PRESSURE INCREASED (Blood pressure 180/98) had resolved. On 26-Jan-2021, HEADACHE (headache) had resolved. At the time of the report, DIZZINESS (super dizzy), ASTHENIA (super weak), PARAESTHESIA (tingling in hands and feet), VACCINATION SITE WARMTH (hotness in left arm at the injection site), MUSCULOSKELETAL DISCOMFORT (hotness in left shoulder) and MUSCULOSKELETAL DISCOMFORT (hotness in left neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
I had the vaccine, but got shingles anyway/Suspected vaccination failure; Got shingles anyway; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 08-MAY-2022 Reporters comment: The patient self-reported the case via interactive digital media and described the occurrence of suspected vaccination failure. After receiving Shingles vaccine, the patient got shingles anyway. Additional supportive information: This case was considered as suspected vaccination failure, since the details regarding completion of the primary immunization, time to onset for event and laboratory test confirming shingles were unknown at the time of reporting.
I developed the shingles shortly after my second dose of COVID19 vaccine. See continuation page for more information.
Patient experience hives 30 minutes after shot, and then 1 week later red, itchy burning spots appeared around her joints and inside of her mouth, disappeared within 30 minutes after taking benadryl
Headaches, chills, fever, lack of sleep, dizziness, lack of appetite, fatigue.  Still working on outcome.
received dose from vials beyond 30-day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received dose from vials beyond 30-day use by date) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received dose from vials beyond 30-day use by date). On 09-Jun-2021, EXPIRED PRODUCT ADMINISTERED (received dose from vials beyond 30-day use by date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Date of refrigeration was 07-may-2021. No concomitant medications were reported.  No treatment medications were reported.   This case was linked to MOD-2021-363032 (Patient Link).
swelling on their cheek; chills; headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (swelling on their cheek), CHILLS (chills) and HEADACHE (headache) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced CHILLS (chills) and HEADACHE (headache). On 21-Apr-2021, the patient experienced SWELLING FACE (swelling on their cheek). At the time of the report, SWELLING FACE (swelling on their cheek), CHILLS (chills) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were provided  No treatment medication were provided   Reporter did not allow further contact